IR-Med, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IR-Med, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2024.
  • IR-Med, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$598K, a 49.3% increase year-over-year.
  • IR-Med, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$2.89M, a 49.5% increase year-over-year.
  • IR-Med, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.91M, a 3.7% decline from 2022.
  • IR-Med, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$4.73M, a 27.4% decline from 2021.
  • IR-Med, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.72M, a 394% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.89M -$598K +$581K +49.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$3.47M -$366K +$743K +67% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4.22M -$657K +$693K +51.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$4.91M -$1.27M +$819K +39.2% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-08
Q3 2023 -$5.73M -$1.18M -$323K -37.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$5.41M -$1.11M -$170K -18.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5.24M -$1.35M -$501K -59% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$4.73M -$2.09M -$1.07M -105% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-08
Q3 2022 -$3.66M -$856K -$126K -17.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.54M -$939K +$583K +38.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$4.12M -$849K -$405K -91.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$3.72M -$1.02M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-05-11
Q3 2021 -$730K -$641K -720% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.52M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$444K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$89K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.